Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „emtricitabine“
Suchtreffer
Begriffe & Kennungen
Efavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Glecaprevir/Pibrentasvir/Efavirenz Expected: Concomitant administration of Glecaprevir: ↓ glecaprevir/pibrenta
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Higher tenofovir concentrations could potentiate tenofovir-associated adverse events, including renal disorder
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · In vitro and clinical pharmacokinetic interaction studies have shown the potential for CYP-mediated interactio
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Interactions between efavirenz/emtricitabine/tenofovir disoproxil or its individual component(s) and 11 other
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Levonorgestrel (active metabolite): AUC: ↓ 83% (↓ 79 to ↓ 87) Cmax: ↓ 80% (↓ 77 to ↓ 83) Cmin: ↓ 86% (↓ 80 to
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Medicinal product by therapeutic Effects on active substances levels Recommendation concerning areas Mean perc
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Metamizole Co-administration of efavirenz with metamizole, which is an inducer of metabolising enzymes includi
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · N-monodesmethyl diltiazem: AUC: ↓ 37% (↓ 17 to ↓ 52) Cmax: ↓ 28% (↓ 7 to ↓ 44) Cmin: ↓ 37% (↓ 17 to ↓ 52)
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Other interactions
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Praziquantel Concomitant use with praziquantel is not recommended due to significant decrease in plasma concen
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · QT Prolonging medicinal products Efavirenz/emtricitabine/tenofovir disoproxil is contraindicated with concomit
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Rash developed in 46% of uninfected volunteers receiving efavirenz and clarithromycin. Clarithromycin/Emtricit
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Renally eliminated medicinal products Since emtricitabine and tenofovir are primarily eliminated by the kidney
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Sofosbuvir/velpatasvir and sofosbuvir/velpatasvir/voxilaprevir Co-administration of efavirenz/emtricitabine/te
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · St. John’s wort (Hypericum perforatum) Co-administration of efavirenz/emtricitabine/tenofovir disoproxil and S
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Studies conducted with other medicinal products
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Table 1: Interactions between efavirenz/emtricitabine/tenofovir disoproxil or its individual components and ot
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Tenofovir concentrations not measured, no effect is expected. Maraviroc/Emtricitabine Interaction not studied.
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Tenofovir disoproxil: AUC: ↔ Cmax: ↔ C24h: ↔ OPIOIDS Methadone/Efavirenz Methadone: Concomitant administration
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Tenofovir:
Eintrag öffnen